US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Industry leader Paul Jones joins Vortex Biotech Holdings as new CEO

16th August 2022 – VORTEX BIOTECH HOLDINGS, a leading oncology liquid biopsy company that operates at the junction of the rapidly growing liquid biopsy, cell analytics and oncology markets, announces the appointment of Paul Jones as CEO.Vortex BioSciences, a portfolio company of NetScientific PLC, the international Life Sciences, and Sustainability Technology investment and commercialisation Group, is focused on developing its position in the multi-billion dollar oncology liquid biopsy market, which is estimated to grow at 14% CAGR by 2030*. Vortex’s core technology allows for the capture

EMV Capital advises on a restructuring and investment in Vortex Biotech Holdings. Appointment of new Vortex CEO to drive growth.

London, UK, 16[th] August 2022 – International venture capital investor and adviser, EMV Capital Ltd (EMV Capital), is pleased to announce that it has advised on the restructuring and investment in Vortex Biotech Holdings, a leader in the oncology liquid biopsy market. The company also appointed industry veteran Paul Jones to drive growth.EMV Capital advised Deeptech Disruptive Growth Investments (Deeptech) on its acquisition of Vortex, Inc. in 2019 for £113,000, following c.$30m of previous investments taking its sophisticated liquid biopsy platform to first sales. Since then, EMV Capital

EMV Capital leads a £1.6m investment into Q-Bot Ltd

EMV Capital announces that it has led a £1.6m investment into Q-Bot Ltd, the UK’s leading developer of robotics in the construction retrofit industry.  · The transaction enables Q-bot to accelerate sales of its ‘Robot as a Service’ offering to retrofit millions of homes in the UK and internationally, a multi-billion unexplored market · Q-Bot’s award winning and patented technology automates underfloor insulation, helping to save energy, increase comfort and reducing heating bills · Following a strategy review in 2021, Q-Bot is now accelerating growth in the UK and internationally

NetScientific PLC Preliminary Results for the year ended 31 December 2021

Good results demonstrate excellent progress in growth strategy to realise shareholder returns NetScientific plc (AIM: NSCI), the international life sciences and sustainability, technology investment and commercialisation group, announces its preliminary results for the year ended 31 December 2021. This was an excellent year of progress for the company as shown in the results. Implementation of its planned growth strategy  has accelerated and delivered a step change, both strategically and tactically.NetScientific plc (AIM: NSCI), the international life sciences and sustainability,

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media